Nebulized long-acting vs. short-acting inhalers for COPD attack in ER
Treatments studied
Part of Lungs & breathing clinical trials.
This trial compares two types of inhaled treatments for people having a COPD flare-up in the emergency room. One group gets a long-acting medicine through a nebulizer, the other gets a short-acting one. The goal is to see which helps breathing better during an attack.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years old or older
- You have been told you have COPD by a doctor or in your medical records
- You are in the ER now because of a COPD flare-up or breathing failure related to COPD
- You can understand the study and sign a consent form
- You are not allergic to formoterol or revefenacin (two study inhaler medicines)
- You are not currently on a breathing tube or ventilator
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is looking at patients with a serious worsening of their chronic obstructive pulmonary disease (COPD) who need intensive care. It aims to gather information to help improve treatment for these severe episodes.
This trial studies a coordinated (multidisciplinary) care program for people with severe COPD who were recently hospitalized for worsening breathing symptoms. It may help reduce future flare-ups and improve day-to-day breathing by coordinating multiple types of care in a COPD center.
This study compares two ways to deliver long-acting bronchodilator medications for COPD: a nebulizer (machine that turns liquid medicine into a mist) versus a handheld inhaler. The goal is to see which method works better for people with moderate to severe COPD symptoms.
This trial tests a new way to diagnose and treat chronic obstructive pulmonary disease (COPD) flare-ups (sudden worsening of symptoms). It aims to help people who come to the emergency room with a COPD flare-up get better care and follow-up.
This study is for people with COPD who go to the emergency room for a moderate or severe flare-up. It looks at how they are doing after their visit and whether their current inhaler treatment is working well.
This study looks at people hospitalized for a COPD flare-up (“exacerbation”). It may help improve how flare-ups are treated because participants need to receive the usual rescue medicines like steroids and/or antibiotics and then follow a study plan.
Hear when a new COPD Exacerbation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.